Show simple item record

Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia

dc.contributor.authorWang, Zhihong J.en_US
dc.contributor.authorOnwuzurike, Nkechien_US
dc.contributor.authorCallaghan, Michael U.en_US
dc.contributor.authorRajpurkar, Madhvien_US
dc.contributor.authorChitlur, Meera B.en_US
dc.contributor.authorLusher, Jeanne M.en_US
dc.date.accessioned2008-08-04T15:13:45Z
dc.date.available2009-09-02T14:40:29Zen_US
dc.date.issued2008-09en_US
dc.identifier.citationWang, Zhihong J.; Onwuzurike, Nkechi; Callaghan, Michael U.; Rajpurkar, Madhvi; Chitlur, Meera; Lusher, Jeanne M. (2008). "Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia." Pediatric Blood & Cancer 51(3): 416-418. <http://hdl.handle.net/2027.42/60454>en_US
dc.identifier.issn1545-5009en_US
dc.identifier.issn1545-5017en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/60454
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18493997&dopt=citationen_US
dc.description.abstractWe report a case of concurrent type 2B von Willebrand disease (VWD) and immune thrombocytopenia (ITP). The patient had characteristic loss of von Willebrand factor (VWF) high molecular weight multimers (HMWM) but a normal platelet count in the initial 8 years after diagnosis of type 2B VWD. When he developed severe thrombocytopenia, however, both his VWD indices and VWF HMWM normalized. As his platelet count increased, he again lost the HMWM and his VWD indices decreased. These results suggest that the severe thrombocytopenia led to decreased clearance of VWF, especially the HMWM. Pediatr Blood Cancer 2008;51:416–418. © 2008 Wiley-Liss, Inc.en_US
dc.format.extent127528 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherCancer Research, Oncology and Pathologyen_US
dc.titleDecreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopeniaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherDivision of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan ; Division of Hematology/Oncology, Children's Hospital of Michigan, 3901 Beaubien, Detroit, MI 48201.en_US
dc.contributor.affiliationotherDepartment of Pediatrics, Hurley Medical Center, Flint, Michiganen_US
dc.contributor.affiliationotherDivision of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationotherDivision of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationotherDivision of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationotherDivision of Hematology/Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michiganen_US
dc.identifier.pmid18493997en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/60454/1/21593_ftp.pdf
dc.identifier.doihttp://dx.doi.org/10.1002/pbc.21593en_US
dc.identifier.sourcePediatric Blood & Canceren_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.